Danvers, Mass. – The National Scleroderma Foundation, the leading nonprofit funder of peer-reviewed research to discover the cause, understand the mechanisms, and overcome scleroderma forever, is proud to announce that Amgen, formerly Horizon Therapeutics, in honor of the Foundation’s 25th anniversary, has generously committed to match up to $25,000 in donations for the 2023 GivingTuesday event.
Launched in 2012 as a simple idea to create a day that encourages people to do good, GivingTuesday is now a global generosity movement, unleashing the power of people and organizations to transform their communities and their world. GivingTuesday will kick off the generosity season this year by inspiring people to give back on November 28, 2023, and throughout the year.
“GivingTuesday inspires people all around the world to embrace their power to drive progress around the causes they care about, not just on one day but throughout the year,” said Asha Curran, GivingTuesday’s CEO, and co-founder.
“The National Scleroderma Foundation is proud to partner with Amgen in supporting the amazing scleroderma community we serve this GivingTuesday,” said Mary Wheatley, CEO of the National Scleroderma Foundation. “By matching individual donations, Amgen is really boosting the power of these essential funds that will help us in our work toward a cure for this disease. On the 25th anniversary of the Foundation, this is a wonderful partnership to celebrate!”
“We’re honored to have a meaningful relationship with the National Scleroderma Foundation and come together on GivingTuesday to amplify the voices of the scleroderma community and raise awareness about the unmet treatment challenges for this disease,” said Matt Flesch, vice president, Product Communications and Patient Advocacy, Rare Disease at Amgen.
Those who are interested in joining the National Scleroderma’s GivingTuesday initiative can visit scleroderma.org/givingtuesday.
Scleroderma is a rare rheumatic disease that affects connective tissue and the vascular system causing an overproduction of collagen (fibrosis) in the skin (localized scleroderma), and the internal organs (systemic sclerosis), which can be life-threatening. Anyone can have scleroderma. The cause is not yet known, and there is no cure.
About National Scleroderma Foundation
A relentless force in finding a cure and improving the lives of people affected by scleroderma, the National Scleroderma Foundation advances medical research, promotes disease awareness, and provides support and education to people with scleroderma, their families and support networks. Supported by a network of thousands of individuals across the United States, the Foundation is the leading nonprofit funder of peer-reviewed research to discover the cause, understand the mechanisms, and overcome scleroderma forever.
GivingTuesday is a global generosity movement unleashing the power of people and organizations to transform their communities and the world. GivingTuesday was created in 2012 as a simple idea: a day that encourages people to do good. Over the past ten years, it has grown into a global movement that inspires hundreds of millions of people to give, collaborate, and celebrate generosity.
Whether it’s making someone smile, helping a neighbor or stranger out, showing up for an issue or people we care about, or giving some of what we have to those who need our help, every act of generosity counts, and everyone has something to give. GivingTuesday strives to build a world in which the catalytic power of generosity is at the heart of the society we build together, unlocking dignity, opportunity, and equity around the globe.